In a recent secondary analysis of the trial, researchers found that daily aspirin increased risk for major GI bleeding by about 60% overall in older adults. ... 61% increased risk for clinically important GI bleeding at 5 years, compared with placebo.
The device delivers a mineral blend to sites of upper or lower GI bleeding and is applied during an endoscopic procedure. ... The FDA has permitted marketing of the Hemospray device to treat most types of upper or lower GI bleeding, the agency announced
For patients with upper GI bleeding, the Glasgow Blatchford score most accurately predicted hospital-based interventions or death, according to a recent comparison of risk scoring systems. ... The prospective study included 3,012 patients presenting with
An international multidisciplinary consensus group has updated its 2010 recommendations for the management of patients with nonvariceal upper gastrointestinal (GI) bleeding. ... Perform endoscopy within 24 hours of presentation in patients admitted with
Early colonoscopy (i.e., within 24 hours) did not improve outcomes among patients hospitalized with lower gastrointestinal (GI) bleeding, according to a new meta-analysis. ... Although early colonoscopy within 24 hours is generally safe it does not
A recently developed clinical prediction model may help determine when acute lower GI bleeding can be safely managed on an outpatient basis. ... hospitals with lower GI bleeding, as well as compared with other existing risk scores.
Incidence of hospitalization for upper gastrointestinal (GI) bleeding after starting oral anticoagulation was highest in patients prescribed rivaroxaban, lowest for patients prescribed apixaban, and generally lower in patients who were receiving
Attrition bias was also an important concern. Tranexamic acid benefit has not been shown in lower GI bleeding. ... placebo in a [heterogeneous] population of patients with upper or lower GI bleeding.
Patients were eligible if they had evidence of obscure GI bleeding (defined as iron deficiency anemia, a decrease in hemoglobin concentration of 20 10. ... after eight weeks, indicating that the clinical relevance of obscure GI bleeding in this study may
GI bleeding was more common among patients taking warfarin than among those taking NOACs, according to a recent study of U.S. ... This should “allay the concerns of early reports suggesting that the risk of GI [bleeding] is higher with NOACs than that